对多发性骨髓瘤患者的多组体分析,这些患者对一线治疗的反应不同
Bo Zheng1, Ke Yi2, Yajun Zhang2
1Nuclear Radiation Injury Protection and Treatment Department, Navy Medical Center of PLA, Naval Medical University, Huaihai West Road No. 338, Shanghai, 200050, China. bozheng0923@qq.com.
了解多发性骨髓瘤 (MM) 基因组背景是治疗的关键. 这项研究揭示了MM患者不同的遗传和基因表达模式,从而导致治疗反应的预测模型.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 文字转录学 (Transcriptomics) 是一个学科.
背景情况:
- 多发性骨髓瘤 (MM) 治疗疗效因基因组背景而异.
- 影响MM中差异性治疗反应的特定突变和转录格局在很大程度上仍未被描述.
研究的目的:
- 将MM患者的突变和转录特征划分出来,MM患者对一线治疗的反应不同.
- 开发一种MM患者治疗反应的预测模型.
主要方法:
- 分析了200多名MM患者 (MMRF-COMPASS项目) 的整体外体组测序 (WES) 和转录组数据.
- 使用R包 maftools进行体质突变和突变特征的评估.
- 使用R包DESeq2计算差异基因表达,通过LASSO回归进行特征选择.
主要成果:
- 新发现的复发性突变基因 (例如,TTN,MUC16) 被确定. 在非完全缓解 (非CR) 组中,TP53突变更频繁.
- 在CR患者中,与DNA修复相关的突变特征得到了丰富,而NF-kappa B和TGF-β通路活性被抑制.
- 一个基于20个基因的转录组预测模型显示了预测治疗反应的有希望的准确性.
结论:
- 独特的突变和转录特征与多发性骨髓瘤的治疗反应相关.
- 一种新的20基因预测模型显示,它有可能指导新诊断的MM患者的第一线治疗决策.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
